GRAFT FAILURE

Clinical trials for GRAFT FAILURE explained in plain language.

Never miss a new study

Get alerted when new GRAFT FAILURE trials appear

Sign up with your email to follow new studies for GRAFT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 2 Completed 3 Terminated 1

Drug trial aims to rescue failing transplants

Disease control Terminated

This study tested if a drug called eltrombopag could help patients whose blood cell counts remained dangerously low after a stem cell transplant for leukemia, a condition known as poor graft function. The goal was to see if the drug could boost platelet, red blood cell, and white…

Matched conditions: GRAFT FAILURE

Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

GRAFT FAILURE

Get alerted when new GRAFT FAILURE trials appear

Drug trial aims to rescue failing transplants